V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003970 | 330001980 | null | 64.2 | Neo-adjuvant (N) | null | 2017-04-28 | CAP | null | N | 330015204 | CAP |
| 330003971 | 330001981 | null | null | Palliative (P) | 2015-12-06 | 2015-12-06 | GemCarbo Days 1+8 | N | N | 330015222 | GEMCARBO |
| 330003972 | 330001981 | 1.71 | 95.4 | Palliative (P) | 2017-01-03 | 2017-01-05 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330015222 | CISPLATIN + GEMCITABINE |
| 330003973 | 330001981 | 1.65 | 85.9 | Curative (C) | 2016-01-13 | 2016-01-26 | CVP R | N | N | 330015222 | CVP R |
| 330003974 | 330001981 | 0 | 102.5 | Neo-adjuvant (N) | 2014-04-20 | 2014-04-21 | CAP | 02 | null | 330015222 | CAP |
| 330003975 | 330001982 | 1.79 | 78 | Palliative (P) | null | 2015-07-15 | Cetuximab 7 day (>Cycle 2) | N | Y | 330015241 | CETUXIMAB |
| 330003976 | 330001982 | 1.78 | 68.9 | Curative (C) | 2016-07-10 | 2016-07-10 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330015241 | EURO-EWING |
| 330003977 | 330001982 | null | 28.2 | Palliative (P) | 2013-08-20 | 2013-09-02 | CAP | N | N | 330015241 | CAP |
| 330003978 | 330001982 | 0 | 20.8 | Curative (C) | 2017-10-28 | 2017-11-04 | Cetuximab + Radiotherapy Maint | N | Y | 330015241 | CETUXIMAB + RT |
| 330003979 | 330001983 | 1.46 | 42.5 | Adjuvant (A) | 2014-11-24 | 2014-11-24 | CAP | N | N | 330015287 | CAP |
| 330003980 | 330001983 | 1.73 | 78 | Palliative (P) | 2013-04-05 | 2013-04-06 | Carbo F | N | N | 330015287 | CARBO + FLUOROURACIL |
| 330003981 | 330001983 | 1.45 | 22.7 | Neo-adjuvant (N) | 2013-06-26 | 2013-07-08 | EURAMOS TRIAL | N | N | 330015287 | EURAMOS TRIAL |
| 330003982 | 330001983 | 1.55 | 86.2 | Neo-adjuvant (N) | 2017-11-05 | 2017-11-14 | Carbo F | Y | N | 330015287 | CARBO + FLUOROURACIL |
| 330003983 | 330001983 | 1.66 | 44.6 | Neo-adjuvant (N) | 2014-06-18 | 2014-08-02 | Dox + HD Mtx (post PAM) | 02 | N | 330015287 | DOXORUBICIN + HD MTX |
| 330003984 | 330001983 | 1.82 | 79 | Disease modification (D) | 2014-05-27 | 2014-06-24 | CVP R | N | N | 330015287 | CVP R |
| 330003985 | 330001983 | 1.74 | 77.25 | Neo-adjuvant (N) | 2016-08-19 | 2016-08-26 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330015287 | CARBO + FLUOROURACIL |
| 330003986 | 330001983 | 1.64 | 107 | Curative (C) | 2015-03-14 | 2015-03-19 | EW EuroEwing 99 : VIDE | Y | N | 330015287 | EURO-EWING |
| 330003987 | 330013219 | 1.78 | 47.9 | Curative (C) | 2013-12-04 | 2013-12-15 | CETUXIMAB + RT | 2 | N | 330015359 | CETUXIMAB + RT |
| 330003988 | 330013219 | 1.85 | 53.85 | Neo-adjuvant (N) | 2014-05-18 | 2014-05-23 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330015359 | MAP |
| 330003989 | 330001984 | null | 125.7 | Palliative (P) | 2017-09-17 | 2017-12-06 | OST Euramos 1 Closed Trial - AP | 02 | N | 330015385 | MAP |
| 330003990 | 330001985 | 1.76 | 62.3 | Adjuvant (A) | 2013-08-21 | 2013-08-26 | CAP | Y | N | 330015410 | CAP |
| 330003991 | 330001986 | null | 128.6 | null | 2017-07-12 | 2017-07-29 | CETUXIMAB + RT | N | N | 330015414 | CETUXIMAB + RT |
| 330003992 | 330001986 | 1.35 | 68 | Adjuvant (A) | 2017-09-12 | 2017-09-13 | GemCarbo Days 1+8 | N | N | 330015414 | GEMCARBO |
| 330003993 | 330001987 | 1.65 | 52.8 | Curative (C) | 2014-02-04 | 2015-07-18 | CARBO + FLUOROURACIL | Y | N | 330015421 | CARBO + FLUOROURACIL |
| 330003994 | 330007084 | 1.1 | 72 | null | 2017-12-30 | 2018-01-17 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | Y | 330015422 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003995 | 330007084 | null | 89.9 | null | 2017-08-24 | 2017-08-25 | CAP | 02 | N | 330015422 | CAP |
| 330003996 | 330007084 | 1.52 | 86.1 | Neo-adjuvant (N) | 2016-11-08 | 2016-11-08 | EURAMOS TRIAL | 02 | N | 330015422 | EURAMOS TRIAL |
| 330003997 | 330007084 | 1.73 | 94.3 | Palliative (P) | 2014-03-20 | 2014-03-20 | CAP | 2 | N | 330015422 | CAP |
| 330003998 | 330007084 | 1.51 | 76.7 | Neo-adjuvant (N) | 2013-07-26 | 2013-07-26 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330015422 | CARBO + FLUOROURACIL |
| 330004003 | 330011367 | 1.9 | 39.2 | Curative (C) | 2017-10-29 | 2017-10-30 | DA | N | N | 330015468 | DA |
| 330004004 | 330001990 | null | 58.4 | Curative (C) | 2017-03-03 | 2017-03-08 | Carbo F | null | N | 330015472 | CARBO + FLUOROURACIL |
| 330004005 | 330001991 | 0 | 32.6 | Disease modification (D) | 2014-12-28 | 2014-12-28 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | N | N | 330015474 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004006 | 330001992 | 1.72 | 72.4 | Palliative (P) | 2014-09-25 | 2014-09-25 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330015477 | CARBO + FLUOROURACIL |
| 330004007 | 330001992 | 1.59 | 77.4 | Palliative (P) | 2013-09-20 | 2013-09-23 | Cyclophosphamide + Dex + Rituximab | N | N | 330015477 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004008 | 330001992 | 1.57 | 67.3 | Neo-adjuvant (N) | 2017-11-03 | 2017-11-09 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330015477 | CARBO + FLUOROURACIL |
| 330004009 | 330001993 | null | 57.3 | Adjuvant (A) | 2016-12-26 | 2016-12-31 | CYCLOPHOSPHAMIDE + RITUXIMAB | null | N | 330015493 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004010 | 330001993 | 1.7 | 30.4 | Palliative (P) | 2014-06-08 | 2014-06-19 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330015493 | CARBO + FLUOROURACIL |
| 330004011 | 330001994 | null | 28.2 | Palliative (P) | 2013-07-22 | 2013-07-28 | CAP | null | N | 330015500 | CAP |
| 330004014 | 330001996 | 1.55 | 52 | Neo-adjuvant (N) | 2016-12-28 | 2016-12-28 | CAP | N | null | 330015513 | CAP |
| 330004015 | 330001996 | 1.7 | 60.8 | Neo-adjuvant (N) | null | 2015-01-06 | EW EuroEwing 99 : VIDE | N | Y | 330015513 | EURO-EWING |
| 330004016 | 330001996 | null | 62.5 | Curative (C) | 2014-01-31 | 2014-02-20 | CISPLATIN + ETOPOSIDE | N | N | 330015513 | CISPLATIN + ETOPOSIDE |
| 330004017 | 330001997 | 1.78 | 58.2 | Neo-adjuvant (N) | 2013-03-20 | 2013-03-28 | EURO-EWING | 02 | null | 330015523 | EURO-EWING |
| 330004018 | 330001998 | 1.79 | 65 | Palliative (P) | 2014-04-24 | 2014-04-28 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | 330015525 | CARBO + FLUOROURACIL |
| 330004020 | 330001999 | null | 96.7 | Curative (C) | null | 2016-02-03 | CETUXIMAB + RT | null | null | 330015538 | CETUXIMAB + RT |
| 330004021 | 330007091 | null | 77.2 | Not known (9) | null | 2017-05-03 | EURAMOS TRIAL | null | null | 330015541 | EURAMOS TRIAL |
| 330004022 | 330007091 | 0 | 85 | Adjuvant (A) | 2015-10-08 | 2015-10-14 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 330015541 | CISPLATIN + GEMCITABINE |
| 330004023 | 330007091 | null | 70.8 | Curative (C) | null | 2017-05-17 | CETUXIMAB | null | null | 330015541 | CETUXIMAB |
| 330004024 | 330007091 | 1.77 | 109.8 | Curative (C) | 2014-05-14 | 2014-05-27 | CETUXIMAB | N | null | 330015541 | CETUXIMAB |
| 330004025 | 330002000 | 1.67 | 50 | Palliative (P) | 2015-12-09 | 2015-12-09 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330015562 | EURO-EWING |
| 330004026 | 330002001 | 1.67 | 77.9 | Palliative (P) | 2017-08-25 | 2017-09-14 | CAP | 02 | N | 330015588 | CAP |